divislab glp-1 novo nordisk relation A $60 billion industry just found its next growth lever. 💊 With the expiry of a key patent on March 20, 2026, Indian pharma majors are launching generic weight-loss and diabetes drugs Understanding GLP-1 in Diabetes

Protein + Fiber Balance Very low food intake can worsen constipation

The functionality of GLP-1R/CRE Luciferase Reporter HEK293 Cell Line was validated in dose-response assays using the peptide agonists Glucagon-like peptide 1 (7-37), Exendin-4, Lixisenatide, GLP-1 moiety from dulaglutide, Semaglutide, Tirzepatide and Retatrutide

Berberine, the primary named active ingredient in LeviaPatch, has a meaningful research record in metabolic health - oral berberine studies have documented modest reductions in body weight, BMI, and blood glucose markers

There are also risks with these GLP-1 medications, so anything that can be done to increase GLP-1 levels naturally should be considered as an alternative

Again, these were separate studies and the percentages should not be interpreted as proof that one medication is more constipating than another